drugset / Trial / NCT02744495

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery

NCT02744495

Phase 3 Completed 502 enrolled Hôpital Privé de Parly II - Le Chesnay
RandomizedParallel-groupOpen-labelPrevention

Summary

To investigate the role of postoperative nausea and vomiting risk factors assessment after cardiac surgery. We designed a randomized controlled study comparing standard care (no risk factor assessment and no intervention) with prophylaxis of postoperative nausea and vomiting after cardiac surgery in high risk patients. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors (if risk score is over 2) in the intervention arm.

Timeline

Start
2016-02
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 4 mg
Subject Droperidol Small molecule 0.625 mg

Indications

No indication recorded.